SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

July 28, 2003

Date of Report (Date of
earliest event reported)

NeoRx Corporation

(Exact Name of Registrant as Specified in Charter)

Washington	0-16614	91-1261311
(State or Other Jurisdiction of Incorporation)	(Commission File No.)	(IRS Employer Identification No.)
300 Elliot Avenue West, Suite 500, Seattle, WA		98119
(Address of principal executive offices)		(Zip Code)
(206) 281-7001
(Registrant’s telephone number, including area code)

Item 7.    Financial Statements, Pro Forma Financial Information and Exhibits

(c)           Exhibits

                99.1         Press Release of NeoRx Corporation, dated July 28, 2003

Item 12. Results of Operations and Financial Condition

On July 28, 2003, NeoRx Corporation issued a press release announcing its second quarter earnings for the fiscal quarter ended June 30, 2003.  A copy of the press release is attached hereto as Exhibit 99.1.

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NeoRx Corporation
Dated:  August 1, 2003	By	/s/ Melinda G. Kile
		Melinda G. Kile
		Vice President, Finance

3

EXHIBIT INDEX

Exhibit No.	Description
99.1	Press Release dated July 28, 2003

4